Company Filing History:

4 out of 3,580

American Cyanamid Company

patents

American Home Products Corporation

patents

4. 1 out of 113

Wyeth Holdings Corporation

patents

Years Active: 2001-2008

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7332506 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2008-02-19),

2. 7148235 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2006-12-12),

3. 6939870 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2005-09-06),

4. 6825354 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors (2004-11-30),

5. 6462073 - N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2002-10-08),

6. 6342508 - N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2002-01-29),

7. 6340691 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors (2002-01-22),

8. 6197791 - N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2001-03-06),

9. 6172057 - N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2001-01-09),

Title: Jamie Marie Davis: Innovator in Neurological Treatments

Introduction

Jamie Marie Davis is a notable inventor based in Nyack, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. With a total of 9 patents to his name, Davis has established himself as a key figure in the development of innovative compounds aimed at improving mental health.

Latest Patents

Among his latest patents, Davis has developed substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression. This compound is represented by a specific formula, wherein A denotes various heterocycles. The patent details a composition containing this compound and outlines methods for treating disorders of the serotonin-affected neurological systems utilizing such a compound or composition. This innovative approach highlights his commitment to addressing complex neurological issues.

Career Highlights

Throughout his career, Jamie Marie Davis has worked with prominent companies in the pharmaceutical industry, including American Cyanamid Company and Wyeth. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field.

Collaborations

Davis has collaborated with several talented individuals, including Aranapakam Mudumbai Venkatesan and George Theodore Grosu. These partnerships have further enhanced his work and led to advancements in his research.

Conclusion

In summary, Jamie Marie Davis is a distinguished inventor whose work in the treatment of depression has made a significant impact on the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving mental health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com